JB Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Sell
404
-8
-2% -$3.84K 0.01% 271
2026
Q1
$203K Sell
412
-6,260
-94% -$3.4M 0.01% 253
2025
Q4
$3.87M Sell
6,672
-4,791
-42% -$2.71M 0.16% 65
2025
Q3
$5.56M Sell
11,463
-440
-4% -$205K 0.24% 48
2025
Q2
$4.83M Buy
11,903
+4,676
+65% +$1.96M 0.23% 49
2025
Q1
$3.6M Buy
7,227
+231
+3% +$125K 0.2% 62
2024
Q4
$3.64M Buy
6,996
+2,462
+54% +$1.35M 0.2% 53
2024
Q3
$2.8M Sell
4,534
-1,320
-23% -$781K 0.16% 81
2024
Q2
$3.24M Buy
5,854
+151
+3% +$86.5K 0.2% 53
2024
Q1
$3.32M Buy
5,703
+490
+9% +$275K 0.22% 58
2023
Q4
$2.77M Sell
5,213
-439
-8% -$212K 0.2% 61
2023
Q3
$2.86M Sell
5,652
-8,057
-59% -$4.29M 0.24% 62
2023
Q2
$7.15M Buy
13,709
+184
+1% +$99.3K 0.6% 26
2023
Q1
$7.8M Buy
13,525
+4,728
+54% +$2.66M 0.71% 22
2022
Q4
$4.84M Buy
8,797
+538
+7% +$285K 0.47% 46
2022
Q3
$4.19M Buy
+8,259
New +$4.62M 0.46% 45

Other funds holding TMO

JB Capital's TMO Position: Q2 2026 in Review

JB Capital reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, selling an estimated $3.84K and leaving 404 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #271.

JB Capital first reported a position in TMO in Q3 2022 and has held it in 16 quarters since. The position peaked at $7.8M in Q1 2023. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • JB Capital held 404 shares of Thermo Fisher Scientific worth $203K as of Q2 2026.
  • JB Capital sold 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
  • Thermo Fisher Scientific made up 0.01% of JB Capital's portfolio in Q2 2026, its #271 holding.
  • JB Capital first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 16 quarters since.
  • JB Capital's Thermo Fisher Scientific position peaked at $7.8M in Q1 2023.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on JB Capital's 13F filing for Q2 2026, filed 29 Jul 2026.